In vitro tube formation was evaluated using the
Angiogenesis Assay Kit (PromoCell, Heidelberg, Germany; PK-CA577-K905) according to the manufacturer’s instructions. Briefly, 50 μL/well ECM solution was added to prechilled 96-well plates and incubated for 1 h at 37 °C to form a gel. HAMON or ISO-HAS-B cells were transfected with control or NECTIN4 siRNA for 48 h, seeded into the ECM-treated wells at a density of 1–2 × 10
4 cells/well, and incubated for 24 h at 37 °C in 5% CO
2. To inhibit PI3K/Akt, Src, or VEGFR2, or to activate Src, cells were treated with DMSO (0.1%), LY294002 (10 μM), dasatinib (100 nM), cabozantinib (10 μM), or MLR-1023 (1 μM) respectively for 48 h at 37 °C in 5% CO
2, seeded into the ECM-treated wells, and then incubated for 24 h at 37 °C in 5% CO
2. HUVEC were used as a positive control because, in this assay system, they form tubular structures. After incubation, cells were observed under a microscope and images were captured using a
microscope camera system (Nikon). The number of tubules, tubule length, and the number of junctions were measured using ImageJ software (National Institutes of Health, Bethesda, MD).
Tanaka Y., Murata M., Tanegashima K., Oda Y, & Ito T. (2022). Nectin cell adhesion molecule 4 regulates angiogenesis through Src signaling and serves as a novel therapeutic target in angiosarcoma. Scientific Reports, 12, 4031.